Expert Cancer Panel: Stage IIIB ALK-rearranged adenocarcinoma of the left lung

Stage 3A Node-Positive Lung Adenocarcinoma with ALK Rearrangement - Case Based Panel DiscussionsПодробнее

Expert Cancer Panel: Stage IIIB adenocarcinoma w/ progression on NAC and positive marginsПодробнее

Expert Cancer Panel: Oligometastatic lung cancer, brain met w/ ALK rearrangement and BRAF Gly469GluПодробнее

Expert Cancer Panel: Stage IIB T2bN1M0 lung adenocarcinomaПодробнее

Expert Cancer Panel: Completely resected stage IIIA SCLC, initially staged as adenocarcinomaПодробнее

Expert Cancer Panel: Stage IV lung adenocarcinoma following progression on atezolizumabПодробнее

Expert Cancer Panel: Elderly patients w/ early stage lung adenocarcinoma amenable to resectionПодробнее

Expert Cancer Panel: pT2aN2 stage IIIA adenocarcinomaПодробнее

Diagnosis of Metastatic ALK-Rearranged NSCLCПодробнее

Expert Cancer Panel: Stage IVB lung cancer (RET+/PD-L1 50%) w/ seizures from innumerable brain metsПодробнее

Expert Cancer Panel: Isolated hilar recurrence s/p resection of pT2NX adenocarcinoma of the lungПодробнее

Expert Cancer Panel: Lung squamous cell carcinoma s/p lobectomyПодробнее

Expert Cancer Panel: Non-smoker w/ metastatic lung adenocarcinoma to the brainПодробнее

LUNGIVITY- Is it time raise the bar for ALK rearranged NSCLC?Подробнее

Expert Cancer Panel: EGFR+ lung adenocarcinoma, on osimertinib but stopped due to pneumonitisПодробнее

Debate: Surgery for stage IIIa patients with lung cancer? - NoПодробнее

Patient Success Stories: Metastatic Lung Adenocarcinoma with ALK-rearrangement, Ross Camidge MD, PhDПодробнее

Gary Brausen survived Stage 3B lung cancer | bronchoscopy | adenocarcinoma | cisplatin | alimtaПодробнее

Highlights on adjuvant alectinib in early ALK positive NSCLC: The ALINA studyПодробнее